Literature DB >> 18570897

Platelet-derived growth factor signaling through ephrin-b2 regulates hepatic vascular structure and function.

David Semela1, Amitava Das, Daniel Langer, Ningling Kang, Edward Leof, Vijay Shah.   

Abstract

BACKGROUND & AIMS: Cirrhosis is associated with prominent changes in sinusoidal structure and function. Although the resident pericyte in liver, the hepatic stellate cell (HSC), is well characterized in the process of fibrogenesis, signaling pathways that regulate HSC vascular function are less developed. Because pericyte populations outside the liver are increasingly being recognized as a key cell type for angiogenesis and changes in vascular structure, in this study, we explore new HSC-signaling pathways that regulate sinusoidal structure and function.
METHODS: Real-time video microscopy and quantitative software analysis of vascular tube formation were used to measure HSC angiogenesis in vitro. Platelet-derived growth factor (PDGF) and ephrin-signaling pathways were modulated using molecular and pharmacologic techniques. Complementary whole animal studies were performed to correlate in vitro findings with pericyte functions in vivo.
RESULTS: We show that PDGF promotes a phenotype of HSC evidenced by enhanced HSC-driven vascular tube formation in vitro and enhanced HSC coverage of sinusoids in vivo. This angiogenic phenotype modulates specific pericyte vascular functions including permeability and pressure regulation. Furthermore, we identify a key role for ephrin-B2 as a downstream effector of PDGF signaling.
CONCLUSIONS: These studies elucidate novel HSC-signaling pathways that regulate microvascular structure and function in liver.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18570897      PMCID: PMC2639748          DOI: 10.1053/j.gastro.2008.04.010

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  24 in total

1.  Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization.

Authors:  D Shin; G Garcia-Cardena; S Hayashi; S Gerety; T Asahara; G Stavrakis; J Isner; J Folkman; M A Gimbrone; D J Anderson
Journal:  Dev Biol       Date:  2001-02-15       Impact factor: 3.582

2.  Hepatic stellate cell proliferation is an early platelet-derived growth factor-mediated cellular event in rat cholestatic liver injury.

Authors:  N Kinnman; O Goria; D Wendum; M C Gendron; C Rey; R Poupon; C Housset
Journal:  Lab Invest       Date:  2001-12       Impact factor: 5.662

3.  Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension.

Authors:  D C Rockey; J J Chung
Journal:  Gastroenterology       Date:  1998-02       Impact factor: 22.682

4.  Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis.

Authors:  Craig E Daniels; Mark C Wilkes; Maryanne Edens; Ted J Kottom; Stephen J Murphy; Andrew H Limper; Edward B Leof
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

5.  Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo.

Authors:  Mariarosaria Bucci; Fiorentina Roviezzo; Inmaculada Posadas; Jun Yu; Luca Parente; William C Sessa; Louis J Ignarro; Giuseppe Cirino
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-07       Impact factor: 11.205

6.  A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations.

Authors:  Scott T Magness; Ramón Bataller; Liu Yang; David A Brenner
Journal:  Hepatology       Date:  2004-11       Impact factor: 17.425

7.  Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats.

Authors:  Mercedes Fernandez; Marc Mejias; Ester Garcia-Pras; Raul Mendez; Juan Carlos Garcia-Pagan; Jaime Bosch
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

Review 8.  Angiogenesis in chronic inflammatory liver disease.

Authors:  Jesús Medina; Alicia G Arroyo; Francisco Sánchez-Madrid; Ricardo Moreno-Otero
Journal:  Hepatology       Date:  2004-05       Impact factor: 17.425

9.  Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture.

Authors:  Zhaodong Li; Jonathan A Dranoff; Erick P Chan; Masayuki Uemura; Jean Sévigny; Rebecca G Wells
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

10.  Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.

Authors:  Mercedes Fernandez; Francesco Vizzutti; Juan Carlos Garcia-Pagan; Juan Rodes; Jaime Bosch
Journal:  Gastroenterology       Date:  2004-03       Impact factor: 22.682

View more
  59 in total

1.  Brain pericytes: emerging concepts and functional roles in brain homeostasis.

Authors:  Masahiro Kamouchi; Tetsuro Ago; Takanari Kitazono
Journal:  Cell Mol Neurobiol       Date:  2011-03       Impact factor: 5.046

2.  Fabrication and characterization of an inorganic gold and silica nanoparticle mediated drug delivery system for nitric oxide.

Authors:  Amitava Das; Priyabrata Mukherjee; Sumit K Singla; Praveen Guturu; Megan C Frost; Debabrata Mukhopadhyay; Vijay H Shah; Chitta Ranjan Patra
Journal:  Nanotechnology       Date:  2010-07-08       Impact factor: 3.874

Review 3.  Pathophysiology of portal hypertension and its clinical links.

Authors:  Yeon Seok Seo; Vijay H Shah
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

Review 4.  Liver metastases: Microenvironments and ex-vivo models.

Authors:  Amanda M Clark; Bo Ma; D Lansing Taylor; Linda Griffith; Alan Wells
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-06

5.  Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment.

Authors:  Amitava Das; Uday Shergill; Lokendra Thakur; Sutapa Sinha; Raul Urrutia; Debabrata Mukhopadhyay; Vijay H Shah
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-25       Impact factor: 4.052

Review 6.  Hepatic stellate cells in liver development, regeneration, and cancer.

Authors:  Chunyue Yin; Kimberley J Evason; Kinji Asahina; Didier Y R Stainier
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

Review 7.  Host responses in tissue repair and fibrosis.

Authors:  Jeremy S Duffield; Mark Lupher; Victor J Thannickal; Thomas A Wynn
Journal:  Annu Rev Pathol       Date:  2012-10-22       Impact factor: 23.472

8.  Formation of persistent hyperplastic primary vitreous in ephrin-A5-/- mice.

Authors:  Alexander I Son; Michal Sheleg; Margaret A Cooper; Yuhai Sun; Norman J Kleiman; Renping Zhou
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-19       Impact factor: 4.799

9.  IQGAP1 suppresses TβRII-mediated myofibroblastic activation and metastatic growth in liver.

Authors:  Chunsheng Liu; Daniel D Billadeau; Haitham Abdelhakim; Edward Leof; Kozo Kaibuchi; Carmelo Bernabeu; George S Bloom; Liu Yang; Lisa Boardman; Vijay H Shah; Ningling Kang
Journal:  J Clin Invest       Date:  2013-02-01       Impact factor: 14.808

10.  Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases.

Authors:  Claudia Paternostro; Ezio David; Erica Novo; Maurizio Parola
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.